Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noriko Mitsuiki

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Immunological Reviews|December 20, 2018
What did we learn from CTLA-4 insufficiency on the human immune system?Noriko Mitsuiki, Charlotte Schwab, Bodo Grimbacher
International Journal of Hematology|April 28, 2010
Pharmacokinetic monitoring is still required for intravenous busulfan in SCT for small childrenMasayuki Nagasawa, Noriko Mitsuiki, Toshiaki Ono, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Wiskott-Aldrich syndrome mutation in two Turkish siblings with X-linked thrombocytopeniaGöksel Leblebisatan, Ali Bay, Noriko Mitsuiki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 16, 2016
Severe neonatal CMV infection complicated with thrombotic microangiopathy successfully treated with ganciclovirNoriko Mitsuiki, Keita Tamanuki, Kenshi Sei, et al.
International Journal of Hematology|March 8, 2021
Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHDMasayuki Nagasawa, Noriko Mitsuiki, Masakatsu Yanagimachi, et al.
European Journal of Haematology|September 10, 2017
Effect of reduced-intensity conditioning and the risk of late-onset non-infectious pulmonary complications in pediatric patientsMasayuki Nagasawa, Noriko Mitsuiki, Yuki Aoki, et al.
Clinical Immunology (Orlando, Fla.)|July 4, 2018
CTLA-4 regulates human Natural Killer cell effector functionsVassilios Lougaris, Giovanna Tabellini, Manuela Baronio, et al.
Frontiers in Immunology|December 12, 2022
Case report: Optimized ruxolitinib-based therapy in an infant with familial hemophagocytic lymphohistiocytosis type 3Daiki Niizato, Takeshi Isoda, Noriko Mitsuiki, et al.
International Journal of Hematology|October 2, 2013
Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experienceMasayuki Nagasawa, Teppei Ohkawa, Akifumi Endo, et al.
Clinical Immunology (Orlando, Fla.)|August 30, 2022
Recurrent tandem duplication of UNC13D in familial hemophagocytic lymphohistiocytosis type 3Dan Tomomasa, Eitaro Hiejima, Takayuki Miyamoto, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Immunological Reviews|December 20, 2018
What did we learn from CTLA-4 insufficiency on the human immune system?Noriko Mitsuiki, Charlotte Schwab, Bodo Grimbacher
International Journal of Hematology|April 28, 2010
Pharmacokinetic monitoring is still required for intravenous busulfan in SCT for small childrenMasayuki Nagasawa, Noriko Mitsuiki, Toshiaki Ono, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|June 7, 2016
Wiskott-Aldrich syndrome mutation in two Turkish siblings with X-linked thrombocytopeniaGöksel Leblebisatan, Ali Bay, Noriko Mitsuiki, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 16, 2016
Severe neonatal CMV infection complicated with thrombotic microangiopathy successfully treated with ganciclovirNoriko Mitsuiki, Keita Tamanuki, Kenshi Sei, et al.
International Journal of Hematology|March 8, 2021
Utility of novel T-cell-specific extracellular vesicles in monitoring and evaluation of acute GVHDMasayuki Nagasawa, Noriko Mitsuiki, Masakatsu Yanagimachi, et al.
European Journal of Haematology|September 10, 2017
Effect of reduced-intensity conditioning and the risk of late-onset non-infectious pulmonary complications in pediatric patientsMasayuki Nagasawa, Noriko Mitsuiki, Yuki Aoki, et al.
Clinical Immunology (Orlando, Fla.)|July 4, 2018
CTLA-4 regulates human Natural Killer cell effector functionsVassilios Lougaris, Giovanna Tabellini, Manuela Baronio, et al.
Frontiers in Immunology|December 12, 2022
Case report: Optimized ruxolitinib-based therapy in an infant with familial hemophagocytic lymphohistiocytosis type 3Daiki Niizato, Takeshi Isoda, Noriko Mitsuiki, et al.
International Journal of Hematology|October 2, 2013
Early coagulation disorder after allogeneic stem cell transplantation is a strong prognostic factor for transplantation-related mortality, and intervention with recombinant human thrombomodulin improves the outcome: a single-center experienceMasayuki Nagasawa, Teppei Ohkawa, Akifumi Endo, et al.
Clinical Immunology (Orlando, Fla.)|August 30, 2022
Recurrent tandem duplication of UNC13D in familial hemophagocytic lymphohistiocytosis type 3Dan Tomomasa, Eitaro Hiejima, Takayuki Miyamoto, et al.
Pageof 6